Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster

statnews.com/2025/09/07/summit-therapeutics-lung-cancer-ivonescimab

Summit Therapeutics may have a geography problem with its lung cancer drug ivonescimab.
In a study update reported Sunday, patients from North America and Europe treated with the drug saw their lung cancer return and progress faster than patients from China — a discordant result that…

This story appeared on statnews.com, 2025-09-07 14:47:39.951000.
The Entire Business World on a Single Page. Free to Use →